Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

NCT02121873 is registered in ClinicalTrials.gov with Atossa Therapeutics, Inc. as lead sponsor.

NCT NCT02121873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02121873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
Lead sponsor
Atossa Therapeutics, Inc.
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
August 31, 2012
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, ductal carcinoma in situ, preneoplastic conditions